Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITI-007 in acute schizophrenia
NCT01499563Phase 2Completed
- Sponsor
- Intra-Cellular Therapies
- Start
- Dec 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lumateperone in schizophrenia, sponsored by Intra-Cellular Therapies. Started Dec 2011; status: completed.
02
Drugs
lumateperone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01499563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01499563.